We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $53.9M | Put options by funds: $15.5M

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

24% more capital invested

Capital invested by funds: $2.09B → $2.6B (+$509M)

14% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 65

9% more funds holding

Funds holding: 205 → 224 (+19)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.26% less ownership

Funds ownership: 77.81% → 77.55% (-0.26%)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$52.9M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$21.4M
3
EAM
Eventide Asset Management
Massachusetts
+$15.2M
4
HRCM
Hood River Capital Management
Florida
+$13.1M
5
NAMA
Nikko Asset Management Americas
New York
+$12.5M

Top Sellers

1
Temasek Holdings
Temasek Holdings
Singapore
-$62.3M
2
State Street
State Street
Massachusetts
-$44.1M
3
AIM
ARK Investment Management
Florida
-$17.2M
4
DTC
Deep Track Capital
Connecticut
-$14.3M
5
Millennium Management
Millennium Management
New York
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
OQS
226
Occudo Quantitative Strategies
Florida
– -$1.06M -27,309 Closed
Jennison Associates
227
Jennison Associates
New York
– -$556K -14,359 Closed
JG
228
Jefferies Group
New York
– -$344K -8,897 Closed
SW
229
SteelPeak Wealth
California
– -$314K -8,109 Closed
Simplex Trading
230
Simplex Trading
Illinois
– -$337K -5,916 Closed
SEC
231
Seven Eight Capital
New York
– -$229K -5,908 Closed
HSBC Holdings
232
HSBC Holdings
United Kingdom
– -$221K -5,671 Closed
BCV
233
Banque Cantonale Vaudoise
Switzerland
– -$45K -1,167 Closed
CAPTRUST Financial Advisors
234
CAPTRUST Financial Advisors
North Carolina
– -$44K -1,127 Closed
Walleye Trading
235
Walleye Trading
New York
– -$62.4K -1,094 Closed
CLOS
236
Compagnie Lombard Odier SCmA
Switzerland
– -$42K -1,080 Closed
BBHC
237
Brown Brothers Harriman & Co
New York
– -$35K -909 Closed
PFGIA
238
Patriot Financial Group Insurance Agency
Massachusetts
– -$11K -285 Closed
SFG
239
Steward Financial Group
Texas
– -$5K -140 Closed
PCFFS
240
Pacific Center for Financial Services
California
– -$3K -83 Closed
CWP
241
Concord Wealth Partners
Virginia
– -$2K -54 Closed
UB
242
UMB Bank
Missouri
– -$2K -52 Closed
HR
243
Howe & Rusling
New York
– -$1K -25 Closed
CAL
244
Capital Advisors Ltd
Ohio
– +$171 +3 New
6 7 8 9
10

BEAM Hedge Fund Activity: Q3 2022 in Review

224 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2022, worth a combined $2.6B — up 24% from $2.09B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new BEAM positions and 25 closed out — a net gain of 19 holders — while 74 added to existing stakes and 65 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52.9M. The largest seller was Temasek Holdings, cutting an estimated $62.3M.

  • 224 institutional investors held Beam Therapeutics (BEAM) as of Q3 2022, up from 205 in Q2 2022.
  • Funds reported $2.6B of Beam Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 44 funds opened new Beam Therapeutics positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Beam Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $52.9M added.
  • The largest Beam Therapeutics seller in Q3 2022 was Temasek Holdings, an estimated $62.3M sold.

Based on aggregated 13F filings for Q3 2022.